Annual Cash & Cash Equivalents
$11.78 M
+$2.36 M+25.10%
December 31, 2023
Summary
- As of February 7, 2025, TLSI annual cash & cash equivalents is $11.78 million, with the most recent change of +$2.36 million (+25.10%) on December 31, 2023.
- During the last 3 years, TLSI annual cash & cash equivalents has fallen by -$18.52 million (-61.13%).
- TLSI annual cash & cash equivalents is now -61.13% below its all-time high of $30.30 million, reached on December 31, 2021.
Performance
TLSI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$11.29 M
-$5.19 M-31.51%
September 30, 2024
Summary
- As of February 7, 2025, TLSI quarterly cash and cash equivalents is $11.29 million, with the most recent change of -$5.19 million (-31.51%) on September 30, 2024.
- Over the past year, TLSI quarterly cash and cash equivalents has dropped by -$10.10 million (-47.21%).
- TLSI quarterly cash and cash equivalents is now -47.21% below its all-time high of $21.38 million, reached on September 30, 2023.
Performance
TLSI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TLSI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | -47.2% |
| 3 y3 years | -61.1% | - |
| 5 y5 years | -61.1% | - |
TLSI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.1% | +25.1% | -47.2% | +184.3% |
| 5 y | 5-year | -61.1% | +25.1% | -47.2% | +184.3% |
| alltime | all time | -61.1% | +25.1% | -47.2% | +184.3% |
TriSalus Life Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.29 M(-31.5%) |
| Jun 2024 | - | $16.48 M(+315.1%) |
| Mar 2024 | - | $3.97 M(-66.3%) |
| Dec 2023 | $11.78 M | $11.78 M(-44.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $21.38 M(+216.3%) |
| Mar 2023 | - | $6.76 M(-28.2%) |
| Dec 2022 | $9.41 M(-68.9%) | $9.41 M |
| Dec 2021 | $30.30 M | - |
FAQ
- What is TriSalus Life Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for TriSalus Life Sciences?
- What is TriSalus Life Sciences annual cash & cash equivalents year-on-year change?
- What is TriSalus Life Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for TriSalus Life Sciences?
- What is TriSalus Life Sciences quarterly cash and cash equivalents year-on-year change?
What is TriSalus Life Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of TLSI is $11.78 M
What is the all time high annual cash & cash equivalents for TriSalus Life Sciences?
TriSalus Life Sciences all-time high annual cash & cash equivalents is $30.30 M
What is TriSalus Life Sciences annual cash & cash equivalents year-on-year change?
Over the past year, TLSI annual cash & cash equivalents has changed by +$2.36 M (+25.10%)
What is TriSalus Life Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TLSI is $11.29 M
What is the all time high quarterly cash and cash equivalents for TriSalus Life Sciences?
TriSalus Life Sciences all-time high quarterly cash and cash equivalents is $21.38 M
What is TriSalus Life Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, TLSI quarterly cash and cash equivalents has changed by -$10.10 M (-47.21%)